Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
Am J Clin Nutr. 2011 Aug;94(2):633S-50S. doi: 10.3945/ajcn.110.008227. Epub 2011 Jul 6.
The ability to develop evidence-based clinical guidance and effective programs and policies to achieve global health promotion and disease prevention goals depends on the availability of valid and reliable data. With specific regard to the role of food and nutrition in achieving those goals, relevant data are developed with the use of biomarkers that reflect nutrient exposure, status, and functional effect. A need exists to promote the discovery, development, and use of biomarkers across a range of applications. In addition, a process is needed to harmonize the global health community's decision making about what biomarkers are best suited for a given use under specific conditions and settings. To address these needs, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, US Department of Health and Human Services, organized a conference entitled "Biomarkers of Nutrition for Development: Building a Consensus," which was hosted by the International Atomic Energy Agency. Partners included key multilateral, US agencies and public and private organizations. The assembly endorsed the utility of this initiative and the need for the BOND (Biomarkers of Nutrition for Development) project to continue. A consensus was reached on the requirement to develop a process to inform the community about the relative strengths or weaknesses and specific applications of various biomarkers under defined conditions. The articles in this supplement summarize the deliberations of the 4 working groups: research, clinical, policy, and programmatic. Also described are content presentations on the harmonization processes, the evidence base for biomarkers for 5 case-study micronutrients, and new frontiers in science and technology.
制定基于证据的临床指导方针和有效计划及政策以实现全球健康促进和疾病预防目标的能力取决于有效和可靠数据的可用性。具体而言,在实现这些目标方面,食物和营养的作用需要使用反映营养素暴露、状况和功能影响的生物标志物来开发相关数据。需要促进生物标志物在一系列应用中的发现、开发和使用。此外,需要有一个流程来协调全球卫生界在特定条件和环境下,决定哪些生物标志物最适合给定用途的决策。为了满足这些需求,美国国立卫生研究院下属的儿童健康与人类发育国立研究所(Eunice Kennedy Shriver National Institute of Child Health and Human Development)组织了一次题为“营养与发展的生物标志物:建立共识”的会议,由国际原子能机构主办。合作伙伴包括主要的多边机构、美国各机构以及公共和私营组织。会议认可了这一倡议的实用性,以及 BOND(营养与发展的生物标志物)项目继续开展的必要性。会议就制定一个流程达成了共识,以便向社区通报各种生物标志物在特定条件下的相对优势或劣势以及具体应用。本增刊中的文章总结了 4 个工作组的审议情况:研究、临床、政策和方案。还介绍了关于协调程序、5 种案例研究微量营养素的生物标志物证据基础以及科学和技术新前沿的内容介绍。